ASTRA NAROPIN PROMOTIONS TO HOSPITALS BEGIN IMMEDIATELY FOLLOWING APPROVAL SEPT. 24; LONG-ACTING REGIONAL ANESTHETIC SUPPORTED BY 100 SALES REPS
Executive Summary
Astra has begun hospital sales calls to promote the regional anesthetic Naropin (ropivacaine) following FDA's Sept. 24 approval of the agent.